infection-prevention-2018-scientifictracks

17 / 21

Page 66
conferenceseries.com
Volume 6 Journal of Infectious Diseases & Therapy
ISSN: 2332-0877 Infection Prevention 2018
December 06-07, 2018
December 06-07, 2018 | Valencia, Spain
14th World Congress on
Infection Prevention and Control
Recent Publications:
1. Wang Y, Tian GB, Zhang R, Shen Y, Tyrrell JM, Huang X, Zhou H, Lei L, Li HY, Doi Y, Fang Y, Ren H, Zhong LL, Shen
Z, Zeng KJ, Wang S, Liu JH, Wu C, Walsh TR, Shen J – Prevalence, risk factors, outcomes, and molecular epidemiology
of mcr-1-positive Enterobacteriaceae in patients and healthy adults from China: an epidemiological and clinical study,
Lancet Infect Dis, 2017, 17(4), 390–399;
2. Sala C, Morar A, Morva AA – Antibiotic resistance of gram negative bacteria isolated from meat surface biofilm,
Roum Biotech Lett, 2012, 17(4),7483-7492;
3. Branswell H – Superbug resistant to last-resort antibiotics turns up in Europe, Stat, December 3, 2015, https://www.
;
4. Pătraşcu IV, Chiurciu V, Chiurciu C, Topilescu G-Procedure of production and application of chicken immunoglobulin
[IgY],OSIM Patent no. A/00156 25.02.2014, see OSIM Official Monitor 7/2014, p.26;
5. Patrascu IV, Penescu M, Viasu L – Urinary tract infections (UTI) (2). Escherichia coli resistant to colistin and newly
developed pathology, Romanian Academy Session, April 22, 2017.
Biography
Liliana Viasu MD, head of Laboratory at Teaching Hospital of Nephrology dr.Carol Davila ,Bucharest, Romania and scientific manager of Autoimmunity SRL.
Born in 24th June 1970,graduated in University of Medicine and Pharmacy Carol Davila in Bucharest in 1998.Specialization in Laboratory Medicine, especially
Immunology.20 years of research in autoimmunity, hematology, bone metabolism, immunological disorders also specialization in Translational Medicine. In the
last 2 years participate at the program for Antibiotic resistance of microorganisms, preclinical and clinical human studies and the second generation of immunogen
I-spga that was managed to prepare IMUNOVIP able to react specifically with bacteria by oral treatment of antibiotic-resistant urinary tract infections in women. All
the latest studies were made in collaboration with Pătrașcu Ionel Victor, MVD, PhD president of Activeimmunity SRL.